ISIN | LU2207278073 |
---|---|
Valor Number | 57670939 |
Bloomberg Global ID | |
Fund Name | Kieger Impact Healthcare Fund Class A USD Accumulating |
Fund Provider |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Phone: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fund Provider | Kieger AG |
Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related companies or issuers worldwide (including Emerging Markets) with a focus on issuers that contribute to the realisation of the healthcare related United Nations Sustainable Development Goals ("SDGs"). No guarantee can be given that the investment objective will be achieved. |
Peculiarities |
Current Price * | 78.97 USD | 13.03.2025 |
---|---|---|
Previous Price * | 79.82 USD | 12.03.2025 |
52 Week High * | 88.10 USD | 16.07.2024 |
52 Week Low * | 78.16 USD | 19.12.2024 |
NAV * | 78.97 USD | 13.03.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 87,320,896 | |
Unit/Share Assets *** | 79,730,118 | |
Trading Information SIX |
YTD Performance | +0.71% |
31.12.2024 - 13.03.2025
31.12.2024 13.03.2025 |
---|---|---|
YTD Performance (in CHF) | -2.08% |
31.12.2024 - 13.03.2025
31.12.2024 13.03.2025 |
1 month | -8.43% |
13.02.2025 - 13.03.2025
13.02.2025 13.03.2025 |
3 months | -2.57% |
13.12.2024 - 13.03.2025
13.12.2024 13.03.2025 |
6 months | -8.21% |
13.09.2024 - 13.03.2025
13.09.2024 13.03.2025 |
1 year | -8.20% |
13.03.2024 - 13.03.2025
13.03.2024 13.03.2025 |
2 years | -8.19% |
13.03.2023 - 13.03.2025
13.03.2023 13.03.2025 |
3 years | -9.99% |
14.03.2022 - 13.03.2025
14.03.2022 13.03.2025 |
5 years | -21.03% |
30.09.2020 - 13.03.2025
30.09.2020 13.03.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Tandem Diabetes Care Inc | 4.17% | |
---|---|---|
Amplifon SpA Az nom Post Frazionamento | 3.74% | |
Hikma Pharmaceuticals PLC | 3.73% | |
Exact Sciences Corp | 3.72% | |
DexCom Inc | 3.66% | |
Gilead Sciences Inc | 3.63% | |
Centene Corp | 3.63% | |
Abbott Laboratories | 3.62% | |
GSK PLC | 3.57% | |
BioNTech SE ADR | 3.56% | |
Last data update | 31.12.2024 |
TER *** | 1.21% |
---|---|
TER date *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 1.21% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** |
Sustainable Investment |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |